Contact us to receive a trial version of our software including a 30-minute guide.
Dacima logo

Blog

A cluster-randomized trial to reduce major perinatal morbidity among women with one prior cesarean delivery in Québec (PRISMA trial): study protocol for a randomized controlled trial

Research Center of the CHU de Québec (Laval University, Québec City, QC) is using Dacima Clinical Suite for its PRISMA trial and posted an article in NCBI. STUDY ABSTRACT Background: Rates of cesarean delivery are continuously increasing in industrialized countries, with repeated cesarean accounting for about a third of all cesareans. Women who have undergone a...
Read More

Dacima is first EDC company to receives certification for WHODrug C3 coding from Uppsala Monitoring Centre

Dacima is pleased to announced that it had received certification from the Uppsala Monitoring Centre for its WHODrug coding module in the Dacima Clinical Suite Electronic Data Capture (EDC) software application. Dacima is the first EDC software company to receive certification for the new C3 format of the WHODrug dictionary. The Uppsala Monitoring center (UMC) offer the...
Read More

A bright future for Patient Services

Pharma sector keeps focus on patient-side (data capture) In a couple of previous posts (here and here) we already talked about the emerging importance of data capture from the patient’s perspective. Accenture released this week a detailed report, based on a survey on more than 200 patient services executives, confirming this latest trend while going into much more detail and giving...
Read More

Clinical Data Management still sticking point for Pharmaceutical R&D

Capturing and Managing Clinical Trial Data  Clinical Data Management remains one of the most crucial factors in conducting Clinical Trials to influence the resources during the clinical trials and, eventually, the outcome. A recent survey among clinical operation leaders revealed that a staggering two-thirds still uses spreadsheets to handle data in Clinical Trials. This is one of the most...
Read More